Sterile multifocal osteomyelitis with periostitis and pustulosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:210115OMIM:612852D84.8
Who is this for?
Show terms as
1FDA treatments2Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Sterile multifocal osteomyelitis with periostitis and pustulosis (also known as SAPHO syndrome variant or chronic recurrent multifocal osteomyelitis with pustulosis) is a rare autoinflammatory bone disorder characterized by the combination of sterile (non-infectious) inflammation of multiple bones, periostitis (inflammation of the tissue surrounding the bones), and pustular skin lesions. This condition belongs to the spectrum of autoinflammatory bone diseases and is closely related to SAPHO syndrome (Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis). The disease primarily affects the skeletal system and the skin. Bone involvement typically manifests as pain, swelling, and tenderness at multiple sites, with the long bones, clavicles, and vertebrae being commonly affected. Periostitis leads to new bone formation and thickening around affected areas. The pustular skin component most often presents as palmoplantar pustulosis, with sterile pustules appearing on the palms and soles. The underlying pathophysiology involves dysregulation of the innate immune system, leading to chronic sterile inflammation. Bone biopsies show inflammatory infiltrates without evidence of infectious organisms, distinguishing this condition from infectious osteomyelitis. The disease follows a chronic relapsing and remitting course. Diagnosis is primarily clinical and radiological, supported by the exclusion of infectious causes. Treatment is largely symptomatic and includes nonsteroidal anti-inflammatory drugs (NSAIDs) as first-line therapy, bisphosphonates (particularly pamidronate), corticosteroids, and disease-modifying agents such as methotrexate or sulfasalazine. In refractory cases, biologic therapies targeting TNF-alpha (such as infliximab or adalimumab) or IL-1 (such as anakinra) have shown benefit. The prognosis is variable, with some patients experiencing prolonged remissions while others have a more persistent course with potential for skeletal complications.

Also known as:

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

1 available

Arcalyst

rilonacept· Kiniksa Pharmaceuticals, Ltd.

Maintenance of remission of Deficiency of Interleukin-1 Receptor Antagonist (DIRA)

No actively recruiting trials found for Sterile multifocal osteomyelitis with periostitis and pustulosis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Sterile multifocal osteomyelitis with periostitis and pustulosis community →

Specialists

2 foundView all specialists →
AM
Avindra Nath, M.D.
BALTIMORE, MD
Specialist
PI on 7 active trials
GM
Gina A Montealegre, M.D.
CLEVELAND, OH
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Sterile multifocal osteomyelitis with periostitis and pustulosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Sterile multifocal osteomyelitis with periostitis and pustulosisForum →

No community posts yet. Be the first to share your experience with Sterile multifocal osteomyelitis with periostitis and pustulosis.

Start the conversation →

Latest news about Sterile multifocal osteomyelitis with periostitis and pustulosis

No recent news articles for Sterile multifocal osteomyelitis with periostitis and pustulosis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Sterile multifocal osteomyelitis with periostitis and pustulosis

What is Sterile multifocal osteomyelitis with periostitis and pustulosis?

Sterile multifocal osteomyelitis with periostitis and pustulosis (also known as SAPHO syndrome variant or chronic recurrent multifocal osteomyelitis with pustulosis) is a rare autoinflammatory bone disorder characterized by the combination of sterile (non-infectious) inflammation of multiple bones, periostitis (inflammation of the tissue surrounding the bones), and pustular skin lesions. This condition belongs to the spectrum of autoinflammatory bone diseases and is closely related to SAPHO syndrome (Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis). The disease primarily affects the sk

Which specialists treat Sterile multifocal osteomyelitis with periostitis and pustulosis?

2 specialists and care centers treating Sterile multifocal osteomyelitis with periostitis and pustulosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.